NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Wave Neuroscience announced today the receipt of a generous $1.5 million grant from the Engelstad Foundation that will support Wave Neuroscience’s Phase Two clinical trial currently underway with Texas A&M University Health Science Center (Texas A&M Health) Institute of Biosciences and Technology.

加利福尼亚州纽波特海滩-（商业线）-Wave Neuroscience今天宣布收到Engelstad基金会的150万美元拨款，用于支持Wave Neuroscience目前正在德克萨斯州农工大学健康科学中心进行的第二阶段临床试验（Texas a＆M Health）生物科学与技术研究所。

This significant contribution will accelerate the trial, which aims to develop and validate innovative treatments for Post-Traumatic Stress Disorder (PTSD) and Traumatic Brain Injury (TBI)..

这一重大贡献将加速试验，该试验旨在开发和验证创伤后应激障碍（PTSD）和创伤性脑损伤（TBI）的创新疗法。。

Wave Neuroscience is at the forefront of developing personalized non-invasive therapies for mental health conditions. Their ongoing FDA trial will evaluate the effectiveness of their pioneering technology, Magnetic EEG-guided Resonance Therapy™ (MeRTTM) in treating PTSD and TBI. With this generous funding from the Engelstad Foundation, Wave Neuroscience will be able to accelerate the trial and potentially pave the way for groundbreaking treatment options..

Wave神经科学处于开发针对心理健康状况的个性化非侵入性疗法的最前沿。他们正在进行的FDA试验将评估他们开创性技术——磁脑电图引导共振疗法的有效性™ （MeRTTM）治疗PTSD和TBI。借助恩格尔斯塔德基金会的慷慨资助，Wave Neuroscience将能够加速试验，并有可能为开创性的治疗方案铺平道路。。

'We are deeply grateful for the Engelstad Foundation's incredible generosity and support,' said Fred Walke, Wave’s CEO. 'Their donation will significantly accelerate our efforts to bring new, effective treatments to individuals suffering from PTSD and TBI. We look forward to the potential impact this will have on mental health care.'.

“我们非常感谢恩格尔斯塔德基金会令人难以置信的慷慨和支持，”Wave首席执行官Fred Walke说他们的捐赠将大大加速我们为患有创伤后应激障碍和创伤性脑损伤的个人带来新的有效治疗的努力。我们期待这将对精神卫生保健产生潜在影响。

The Engelstad Foundation is committed to making a difference in the community and improving the lives of individuals through its philanthropic endeavors. This donation is a testament to the Foundation's commitment to fostering innovation and supporting valuable health initiatives.

恩格尔斯塔德基金会致力于通过慈善努力在社区中有所作为，改善个人生活。这次捐赠证明了基金会致力于促进创新和支持宝贵的健康倡议。

“Wave Neuroscience is on the frontlines with such a compassionate mission - to help improve the lives of those with PTSD and TBI,” says Kris Engelstad, trustee of the Engelstad Foundation. “We see this grant as not only an investment in Wave Neuroscience’s incredible treatment efforts and research, but the ultimate wellbeing of so many out there.”.

恩格尔斯塔德基金会受托人克里斯恩格斯塔德说：“波浪神经科学处于这样一个富有同情心的使命的前线-帮助改善创伤后应激障碍和TBI患者的生活。“我们认为这项资助不仅是对Wave神经科学令人难以置信的治疗努力和研究的投资，而且也是其中许多人的最终福祉。”。

PTSD can result from experiencing or witnessing a traumatic event, and the symptoms put a person at greater risk for depression, substance abuse, and a host of psychological disorders. In 2020, approximately 13 million people were suffering from PTSD in the United States (National Center for PTSD). PTSD is often coupled with TBI, and there were approximately 214,110 TBI-related hospitalizations in 2020 (U.S.

创伤后应激障碍可能是由于经历或目睹创伤事件而导致的，症状使人患抑郁症，药物滥用和一系列心理障碍的风险更高。2020年，美国约有1300万人患有创伤后应激障碍（国家创伤后应激障碍中心）。创伤后应激障碍常伴有TBI，2020例约有214110例TBI相关住院（美国）。

Centers for Disease Control)..

疾病控制中心）。。

If you are interested in financially supporting this groundbreaking work, please email Mary Callan, Ph.D., at mary@waveneuro.com, or call 949.229.0586.

如果您有兴趣从财务上支持这项开创性的工作，请发送电子邮件给Mary Callan博士mary@waveneuro.com，或致电949.229.0586。

If you are interested in enrolling in this trial or would like to learn more about it, please visit https://www.mertptsdtrial.com.

如果您有兴趣参加此试验或想了解更多信息，请访问https://www.mertptsdtrial.com.

About Wave Neuroscience:

关于波神经科学：

Wave Neuroscience is a leading organization in mental health care, developing non-invasive therapies for mental health conditions. They are committed to pioneering research and delivering effective treatment options for individuals affected by PTSD, TBI, and other conditions. Learn more about Wave Neuroscience at www.waveneuro.com..

Wave Neuroscience是精神卫生保健领域的领先组织，为精神健康状况开发非侵入性疗法。他们致力于开创性研究，为受PTSD，TBI和其他疾病影响的个人提供有效的治疗选择。在www.waveneuro.com上了解有关Wave神经科学的更多信息。。

About Texas A&M Health:

关于德克萨斯州A＆M健康：

Texas A&M University Health Science Center (Texas A&M Health) comprises five schools (dentistry, medicine, nursing, pharmacy and public health), an integrated University Health Services model, several research centers and institutes, and numerous outpatient clinics with a shared mission of advancing health care for all.

德克萨斯州农工大学健康科学中心（Texas A＆M Health）包括五所学校（牙科，医学，护理，药学和公共卫生），综合大学健康服务模式，多个研究中心和研究所以及众多门诊诊所，共同使命推进所有人的医疗保健。

We serve the state and beyond with campuses and locations in Bryan-College Station, Dallas, Temple, Houston, Round Rock, Kingsville, Corpus Christi, McAllen and Navasota. Learn more at health.tamu.edu or follow @TAMUHealth on Twitter..

我们为该州及其他地区的校园和地点服务于布莱恩学院站，达拉斯，坦普尔，休斯顿，圆石，金斯维尔，克里斯蒂语料库，麦克阿伦和纳瓦索塔。在health.tamu.edu了解更多信息或在Twitter上关注@TAMUHealth。。

About Engelstad Foundation:

关于Engelstad基金会：

The Engelstad Foundation was created in 2002 by Ralph & Betty Engelstad for the purpose of partnering to create solutions in medical research, improving day to day living for people with disabilities and raising the possibilities for high-risk individuals. Since its inception, the Foundation has provided more than $500 million in grants to organizations focused on animal compassion, at-risk individuals, education, historical preservation, medical research and support, people with disabilities and veterans.

恩格尔斯塔德基金会由Ralph＆Betty Engelstad于2002年创建，旨在合作创建医学研究解决方案，改善残疾人的日常生活并提高高风险个人的可能性。自成立以来，该基金会为专注于动物同情，高危人群，教育，历史保存，医学研究和支持，残疾人和退伍军人的组织提供了超过5亿美元的赠款。

For additional information, visit www.engelstadfoundation.com..

For additional information, visit www.engelstadfoundation.com..